Company Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.
The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.
Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 72 |
| CEO | Scott Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
| Phone | 510 984 1761 |
| Website | eksobionics.com |
Stock Details
| Ticker Symbol | EKSO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001549084 |
| CUSIP Number | 282644301 |
| ISIN Number | US2826443010 |
| SIC Code | 3569 |
Key Executives
| Name | Position |
|---|---|
| Scott G. Davis | Chief Executive Officer and Director |
| Jerome Wong | Chief Financial Officer |
| Jason C. Jones | Chief Operating Officer |
| Rachael Anderson | Global Director of Marketing and Strategic Growth |
| Ann Cookson | Human Resources Director |
| Foon Lim Chwee | President of APAC |
| Stephan Aderhold | Senior Vice President and GM of EMEA |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 28, 2024 | 10-Q | Quarterly Report |
| Oct 28, 2024 | 8-K | Current Report |
| Sep 12, 2024 | SCHEDULE 13G | Filing |
| Sep 3, 2024 | 8-K | Current Report |
| Aug 30, 2024 | 424B4 | Prospectus |
| Aug 29, 2024 | EFFECT | Notice of Effectiveness |
| Aug 28, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Aug 5, 2024 | UPLOAD | Filing |
| Jul 29, 2024 | 10-Q | Quarterly Report |